Vaccinex, Inc. Reports Director and Officer Changes
Ticker: VCNX · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Vaccinex board shakeup, new officers appointed, compensation details disclosed.
AI Summary
Vaccinex, Inc. filed an 8-K on March 19, 2025, reporting changes effective March 18, 2025. The filing covers the departure and election of directors, appointment of officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved and the nature of these changes were not provided in the excerpt.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can indicate internal shifts that may impact future performance.
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- March 18, 2025 (date) — Effective date of reported changes
- March 19, 2025 (date) — Filing date of the 8-K
FAQ
What specific changes were made regarding the departure and election of directors?
The filing indicates the departure of certain directors and the election of new ones, but the specific names and circumstances are not detailed in the provided excerpt.
Who are the newly appointed officers of Vaccinex, Inc.?
The filing states that there were appointments of certain officers, but their names and specific roles are not disclosed in the provided text.
What are the details of the compensatory arrangements for the officers?
The filing mentions compensatory arrangements for certain officers, but the specific terms, amounts, or beneficiaries are not detailed in the excerpt.
What is the effective date of the reported changes?
The earliest event reported is dated March 18, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed as of March 19, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding VACCINEX, INC. (VCNX).